GenePeeks

From Wikipedia, the free encyclopedia

GenePeeks is a genetic research company that owns and runs Matchright, a simulation that determines the probability of genetic disorders being present in a child given two people's DNA.

FoundersAnne Morriss
Lee Silver
Location
Quick facts Founders, Location ...
GenePeeks
FoundersAnne Morriss
Lee Silver
Location
Websiteweb.archive.org/web/20181002125843/https://www.genepeeks.com/ October 2018
Close

Overview

GenePeeks simulates the combination of genetic sequences of two people and predicts potential diseases and inherited disorders to find good recipient matches for sperm donors.[1] By simulating the process of reproduction with the two DNA sequences, the company's software (called Matchright) forms a hypothetical child genome to determine the likelihood of the resulting child developing one of around 600 conditions.[1][2] The technology is currently aimed at sperm banks; the first users will be at two fertility clinics in the United States, one of which is Manhattan Cryobank in New York City.[1][3]

The software creates around 10,000 virtual genomes for each donor-recipient pair, and typically rules out 10-15% of donors as bad matches for the recipient.[4] Currently it only searches for single gene genetic conditions, but the company plan to expand the software to look for multiple gene diseases like diabetes and heart disease.[4]

Concern has been raised as to whether the software would allow "designer babies", but the company say that they are not intending to use the system for non-medical purposes.[4][5]

History

GenePeeks was established by Anne Morriss and Lee Silver. Silver is a genetics professor at Princeton University whose work is focused on reproduction and development.[1][4] Morriss was motivated to start the service in part by her own experience of starting a family; her son received an inherited disorder (MCADD) after being conceived with sperm from a donor.[6] The two started GenePeeks after being introduced by a mutual friend.[4]

In January 2014 the company was issued a patent for their algorithms to simulate genetic interactions.[7]

In October 2018, Anne Morriss had left the company and the company website has since been taken down.[8][9]

References

Related Articles

Wikiwand AI